|
Linking genetic subtypes of Alzheimers disease to biological and cognitive heterogeneity |
5K01AG063805-02 |
|
NIA |
2022 |
|
Perioperative Cognitive Anesthesia Network (PeCAN) Program for Alzheimer’s Disease and Related Dementias |
5K07AG066813-03 |
|
NIA |
2022 |
|
Predictive analytics for cognitive decline and Alzheimer’s disease |
5K23AG063993-03 |
|
NIA |
2022 |
|
White matter hyperintensity-associated astrocytopathy in Alzheimers disease and vascular cognitive impairment A targeted histopathologic study using postmortem 7T MRI |
5R01AG056712-05 |
|
NIA |
2022 |
|
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimers Disease: (REGARDS) |
5R01AG061186-04 |
|
NIA |
2022 |
|
Sex-specific cognitive expression and risk in preclinical Alzheimers disease |
5R01AG066088-04 |
|
NIA |
2022 |
|
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimers Disease |
5R01AG068279-03 |
|
NIA |
2022 |
|
Cognitive Dysfunction in Atrial Fibrillation |
5R03AG067207-02 |
|
NIA |
2022 |
|
Identifying best methods for the detection of subtle cognitive decline |
5R03AG070435-02 |
|
NIA |
2022 |
|
Validation of the DCTclock drawing task as a cognitive screening tool for prodromal Alzheimers disease in the Framingham Heart Study |
5R21AG072588-02 |
|
NIA |
2022 |